NCT04494880View on ClinicalTrials.gov

Marcaine Post-Operative Pain Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 9, 2020

Primary Completion Date

December 1, 2022

Study Completion Date

December 31, 2022

Conditions
Effect of Drug
Interventions
DRUG

Bupivacaine Injection

Treatment group receives Marcaine (Bupivacaine) injected into one breast following breast reduction surgery and a saline injection in the other group.

Trial Locations (1)

13210

Upstate University Hospital, Syracuse

All Listed Sponsors
lead

State University of New York - Upstate Medical University

OTHER

NCT04494880 - Marcaine Post-Operative Pain Study | Biotech Hunter | Biotech Hunter